1. Home
  2. TMDX vs HNI Comparison

TMDX vs HNI Comparison

Compare TMDX & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • HNI
  • Stock Information
  • Founded
  • TMDX 1998
  • HNI 1944
  • Country
  • TMDX United States
  • HNI United States
  • Employees
  • TMDX N/A
  • HNI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HNI Office Equipment/Supplies/Services
  • Sector
  • TMDX Health Care
  • HNI Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • HNI Nasdaq
  • Market Cap
  • TMDX 4.8B
  • HNI 2.0B
  • IPO Year
  • TMDX 2019
  • HNI N/A
  • Fundamental
  • Price
  • TMDX $128.97
  • HNI $51.23
  • Analyst Decision
  • TMDX Buy
  • HNI Strong Buy
  • Analyst Count
  • TMDX 10
  • HNI 2
  • Target Price
  • TMDX $127.33
  • HNI $66.50
  • AVG Volume (30 Days)
  • TMDX 838.7K
  • HNI 303.6K
  • Earning Date
  • TMDX 07-30-2025
  • HNI 07-24-2025
  • Dividend Yield
  • TMDX N/A
  • HNI 2.65%
  • EPS Growth
  • TMDX N/A
  • HNI 100.29
  • EPS
  • TMDX 1.41
  • HNI 2.80
  • Revenue
  • TMDX $488,227,000.00
  • HNI $2,538,200,000.00
  • Revenue This Year
  • TMDX $34.07
  • HNI $4.50
  • Revenue Next Year
  • TMDX $20.76
  • HNI $3.48
  • P/E Ratio
  • TMDX $92.35
  • HNI $18.32
  • Revenue Growth
  • TMDX 64.43
  • HNI N/A
  • 52 Week Low
  • TMDX $55.00
  • HNI $39.76
  • 52 Week High
  • TMDX $177.37
  • HNI $58.42
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 59.35
  • HNI 62.03
  • Support Level
  • TMDX $120.36
  • HNI $47.45
  • Resistance Level
  • TMDX $133.49
  • HNI $50.15
  • Average True Range (ATR)
  • TMDX 5.58
  • HNI 0.98
  • MACD
  • TMDX -1.35
  • HNI 0.16
  • Stochastic Oscillator
  • TMDX 60.26
  • HNI 80.14

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

Share on Social Networks: